logo
#

Latest news with #RaymondLifestyle

Textile stocks rally after Govt suspends cotton import duty
Textile stocks rally after Govt suspends cotton import duty

Business Standard

time13 hours ago

  • Business
  • Business Standard

Textile stocks rally after Govt suspends cotton import duty

Shares of six major textile companies surged between 2.14% and 8.22% following the government's decision to suspend the import duty on cotton from August 19 to September 30. Raymond Lifestyle (up 8.22%), Vardhman Textiles (up 7.50%), Arvind (up 3.73%), Welspun Living (up 3.46%), Indo Count Industries (up 2.21%), Gokaldas Exports (up 2.14%) surged. The Finance Ministry on Monday eliminated the 11% duty on cotton imports with immediate effect, citing the need to safeguard competitiveness amid concerns over job losses triggered by steep US tariffs that risk making Indian products uncompetitive in the countrys largest export market. The notification states that the removal of both the import duty and the Agriculture Infrastructure and Development Cess (AIDC) is in the public interest and will remain in force from August 19 through September 30. The textile industry is particularly vulnerable to the elevated US tariffs, especially since the US accounts for a significant share of Indias ready-made garment exports. While India faces a 50% tariff rate, competing countries such as Bangladesh and Vietnam are subject to tariffs of 20%, and Indonesia and Cambodia at 19%. Industry experts welcomed the government's timely intervention, citing that the duty suspension will help bring domestic cotton prices closer to international levels, improve Indias cost competitiveness against regional rivals, and provide a much-needed boost to export prospects.

When people slim down, businesses bulk up
When people slim down, businesses bulk up

Time of India

time12-08-2025

  • Business
  • Time of India

When people slim down, businesses bulk up

Mumbai: The growing popularity of weight-loss drugs Mounjaro and Wegovy may open new growth avenues for non-pharma businesses like textiles, apparel, fitness chains, and food and beverages, besides boosting wellness services such as dental care, aesthetics, dermatology, cosmetology, and plastic surgery . Around 100,000 people in the country are estimated to be using these drugs and the figure is expected to surge to 1.2 million within two years, driving demand across the industries. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program "Made-to-measure and custom tailoring is a trend that will intensify," said Neeraj Nagpal, chief business officer, apparel and retail, at Raymond Lifestyle . by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Undo The apparel maker is weaving health-consciousness into its design strategy - to address a possible rise in demand for "a sharper look" post weight loss. "We have the ingredients, infrastructure, process, knowhow and we have the experience and legacy of delivering at scale to ride on where the wind blows," Nagpal said. Live Events Places like the US where GLP-1 (glucagon-like peptide-1) weight-loss drugs have become a rage, apparel brands are noticing a shift in people's shopping habits. Globally, clothing companies like athletic apparel retailer Lululemon are seeing sizes like S and M flying off the shelves more quickly than usual, according to a report by Investec. "People on GLP drugs are now demanding smaller sizes as their body sizes reduce and this has made companies monitor their sell-through rates to see which sizes are performing better than others," the report stated. Data indicates that customers on GLP-1 drugs are likely to buy more apparel within their first year of being on the medication, it said. The number of Indians using weight-loss drugs is projected to reach four million by 2029-30, aided by an expected drop of up to 80% in the price of semaglutide (Wegovy) after its patent expires in March 2026, paving the way for multiple Indian generics. Several industries are expected to get a tailwind from this. Fitness centres may see a rise in sign-ups as consumers of weight-loss drugs are required to engage in muscle and strength training, said doctors and industry experts. Dermatologists are hoping to receive a lot of patient call with concerns around hair loss, skin sagging, stretch marks and dry skin; dental and aesthetic surgeons are expecting a rise in cases of teeth enamel erosion among people who use weight-loss drugs; orthopaedics foresee muscle loss due to the weight drugs, triggering several cases of back ache and knee pain. "Dermatology will get more tailwind because when people lose weight, it will affect the skin tone and texture, especially if it is unsupervised without proper nutrition and lifestyle change," said Neeraj Tulara, general medicines and infectious diseases specialist at LH Hiranandani Hospital at Powai, Mumbai. The weight-loss medications will also lead to significant muscle loss along with fat loss. That is why these medications are advised with strength training. "If there is a 25-30% weight loss, it will significantly affect the shape of the body," Tulara said. "And once there is muscle loss, the business of dermatologists, cosmetologists and plastic surgeons will increase as more people on weight-loss drugs will approach them to address issues like change in skin tone and texture, skin sagging, etc." Dental would be more of an indirect impact like loss of enamel and gums-related issues due to muscle loss, doctors said. However, any deficiency will happen only when one is not eating properly - because along with weight loss, there is need for dietary consultation and strength training to build muscles, they said. The full impact of the drugs, though, is yet to unfold as it is still early days, they added. "If the weight loss has been unsupervised or very rapid, people come to us for hair loss," said Maithili Kamat, consultant dermatologist and trichologist at Jaslok Hospital. Any calorie deficit due to suppression of appetite and if it is unsupervised without proper nutrients or a high protein diet, there will be hair loss, which also happens after bariatric surgery, she said. Food companies may also see a mark-up in sales of healthy snacks and protein-rich diets. According to a report by consulting major PwC, weight-loss drugs change the way people think about their food and beverage intake.

India's Raymond Lifestyle posts record $168.57 mn Q1 FY26 revenue
India's Raymond Lifestyle posts record $168.57 mn Q1 FY26 revenue

Fibre2Fashion

time07-08-2025

  • Business
  • Fibre2Fashion

India's Raymond Lifestyle posts record $168.57 mn Q1 FY26 revenue

Indian retailer of fabric and fashion products, Raymond Lifestyle Limited, has announced its unaudited financial results for the first quarter (Q1) of fiscal 2026 (FY26), reporting a record revenue of ₹1,475 crore (~$168.57 million)—an increase of 18 per cent year-on-year (YoY), despite it being the seasonally weakest quarter. This performance was primarily led by robust growth in the branded textile and branded apparel segments. EBITDA surged by 36 per cent YoY to ₹122 crore, with margins improving to 8.2 per cent from 7.1 per cent in Q1 FY25, driven by higher sales, an improved product mix, and operational leverage. The profit before tax (PBT) before exceptional items stood at a loss of ₹25 crore, narrowing from ₹32 crore in the same period last year. Raymond Lifestyle Limited has reported record Q1 FY26 revenue of ₹1,475 crore (~$168.57 million), up 18 per cent YoY, led by strong growth in branded textile and apparel. EBITDA rose 36 per cent to ₹122 crore (~$13.94 million). While garmenting declined due to US tariffs, other segments saw healthy gains. The company ended the quarter with 1,675 stores, focusing on retail optimisation. The revenue for branded textile rose 27 per cent YoY to ₹716 crore (~$81.89 million) on the back of strong volume growth and increased wedding dates. EBITDA nearly doubled to ₹103 crore, with margins improving to 14.3 per cent from 9.6 per cent, the company said in a release. For branded apparel, revenue increased 22 per cent YoY to ₹370 crore, with growth seen across all brands and channels. EBITDA grew to ₹19 crore, and margins slightly improved to 5 per cent from 4.9 per cent. Garmenting section's revenue dropped to ₹197 crore from ₹252 crore due to uncertainties stemming from US tariff announcements. EBITDA margin declined to (3.9 per cent) from 3.5 per cent due to scale deleverage. High value cotton shirting saw an increase of 10 per cent YoY in its revenue to ₹205 crore, with EBITDA doubling to ₹20 crore. EBITDA margin improved to 9.5 per cent, supported by strong B2B demand and a better product mix. The company continued its retail network optimisation strategy, exiting under-performing stores. As of June 30, 2025, the store count stood at 1,675, up from 1,540 last year, with newly opened stores expected to mature over time. Raymond Lifestyle ended the quarter with a net-debt position of ₹55 crore, reflecting inventory build-up ahead of the festive and wedding season. 'We are pleased to report improved quarterly performance, driven by signs of demand recovery across our key lifestyle segments. While we remain optimistic, we are also maintaining a cautious stance due to global macroeconomic uncertainties,' said Gautam Hari Singhania, executive chairman of Raymond Lifestyle Limited. 'We are closely monitoring key developments, including the opportunities presented by the UK-India Free Trade Agreement and the challenges posed by US Tariffs. Our agile strategies, combined with these evolving market dynamics, position us well to deliver sustained value to stakeholders.' Fibre2Fashion News Desk (SG)

Raymond Lifestyle reports consolidated net loss of Rs 19.82 crore in the June 2025 quarter
Raymond Lifestyle reports consolidated net loss of Rs 19.82 crore in the June 2025 quarter

Business Standard

time07-08-2025

  • Business
  • Business Standard

Raymond Lifestyle reports consolidated net loss of Rs 19.82 crore in the June 2025 quarter

Sales rise 17.24% to Rs 1430.43 crore Net Loss of Raymond Lifestyle reported to Rs 19.82 crore in the quarter ended June 2025 as against net loss of Rs 23.21 crore during the previous quarter ended June 2024. Sales rose 17.24% to Rs 1430.43 crore in the quarter ended June 2025 as against Rs 1220.12 crore during the previous quarter ended June 2024. Particulars Quarter Ended Jun. 2025 Jun. 2024 % Var. Sales 1430.431220.12 17 OPM % 5.384.89 - PBDT 64.0742.78 50 PBT -24.77-31.79 22 NP -19.82-23.21 15

From Ola Electric to Vodafone Idea— These 8 Nifty 500 stocks have crashed over 50% from their 52-week highs
From Ola Electric to Vodafone Idea— These 8 Nifty 500 stocks have crashed over 50% from their 52-week highs

Mint

time21-07-2025

  • Business
  • Mint

From Ola Electric to Vodafone Idea— These 8 Nifty 500 stocks have crashed over 50% from their 52-week highs

The Indian stock market seems caught in a tight range, with most stocks trading below their 52-week highs. Investor sentiment remains cautious amid lacklustre earnings, stretched valuations, and lingering concerns over a potential trade war sparked by US President Donald Trump's tariff-driven policies. Data reveals that 243 stocks in the Nifty 500 index have dropped over 20 per cent from their 52-week highs, with eight of them plunging more than 50 per cent from their one-year peaks. The Nifty 500 index has gained nearly 2 per cent over the last year, in sync with the benchmark Nifty 50, which has also risen by 2 per cent in the same period. The Indian stock market has remained subdued for nearly two months, with the benchmark Nifty 50 moving within a narrow range due to the absence of fresh positive triggers. The index is just 2 per cent up over the last year. Despite earlier expectations of a new high, the Nifty 50 has slipped nearly 3 per cent from its June 30 level of 25,669. This decline puts it further away from its all-time high of 26,277, which was last touched on September 27, 2023. According to Capitalmarket data, Ola Electric, Raymond Lifestyle, Sterling and Wilson Renewable Energy, Tejas Networks, Vodafone Idea, Akums Drugs, HFCL, and Adani Green are the eight stocks that have crashed more than 50 per cent from their 52-week highs as of Friday, July 18, close. On the other hand, Route Mobile, MMTC, Honasa Consumer, Vedant Fashions, UCO Bank, ITI, Titagarh Rail, IOB, Jupiter Wagons, and IREDA were among the 39 stocks that crashed between 40-50 per cent from their one-year highs. Similarly, Ramkrishna Forgings, Deepak Nitrite, REC, MRPL, SJVN, Tata Tech, Inox Wind, Swiggy, IRFC, Just Dial, Trent, Adani Energy, Bajaj Housing, Hindustan Zinc, Bajaj Auto, JSW Energy, Torrent Power, Cochin Shipyard, Exide Industries, Tata Elxsi, Piramal Pharma, Bharat Forge, Adani Total Gas, TCS, and Alok Industries are among the 72 stocks that have plunged 30-40 per cent from their 52-week highs. The medium to long-term outlook of the domestic market remains positive due to a favourable growth-inflation outlook, better-than-expected monsoon, and a strong influx of retail investors. The single most worry for the Indian stock market is the delay in the successful signing of a trade agreement with the US. Otherwise, the domestic economic scenario remains strong- GDP growth above 6 per cent, healthy monsoon, low inflation regime, over 15 per cent decline in crude oil prices from their 52-week highs, and anticipation of continued reversal of interest rate, augur well for the domestic market," said G. Chokkalingam, the founder and the head of research, at Equinomics Research Private Limited. Read all market-related news here Read more stories by Nishant Kumar Disclaimer: This story is for educational purposes only. The views and recommendations expressed are those of individual analysts or broking firms, not Mint. We advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and circumstances may vary.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store